Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma

Mostrar otras versiones (1)

Metastatic renal cell carcinoma (RCC) seems to be resistant to conventional chemo- and radiotherapy and the general treatment regimen of cytokine therapy produces only modest responses while inducing severe side effects. Nowadays standard of care is the treatment with VEGF-inhibiting agents or mTOR...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäkel, Clara E., Hauser, Stefan, Rogenhofer, Sebastian, Müller, Stefan C., Brossart, P., Schmidt-Wolf, Ingo G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501961/
https://www.ncbi.nlm.nih.gov/pubmed/23193418
http://dx.doi.org/10.1155/2012/473245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501961/
https://www.ncbi.nlm.nih.gov/pubmed/23193418
http://dx.doi.org/10.1155/2012/473245

Ejemplares similares